DaVita Inc <DVA.N>: Bofa Global Research Raises Price Objective to $170.00 From $145.00
DVA•Related News
Amgen, Inc. <AMGN.O>: Oppenheimer raises target price to $450 from $400
AMGN•
Nuburu wins Italian Golden Power clearance for planned 70% Tekne acquisition
BURU•
Street View: Growth drugs lift Pfizer outlook, but execution remains key
PFE•
Custom Truck One Source, Inc. <CTOS.N>: Oppenheimer Raises Target Price to $13 From $11
CTOS•
ADP: US private-sector job growth slows to 44,000 in July
ADP•